DOI:
10.1055/s-00000054
Pharmacopsychiatry
LinksClose Window
References
Homolak J, Kodvanj I.
Widely available lysosome targeting agents should be considered as potential therapy for COVID-19.
Int J Antimicrob Agents 2020;
56: 106044
We do not assume any responsibility for the contents of the web pages of other providers.